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The Influence of Aging on the Prognostic Value of the Revised Cardiac
Risk Index for Postoperative Cardiac Complications in Vascular Sur-
gery Patients
Welten G.M.J.M., Schouten O., van Domburg R.T., Feringa H.H.H.,
Hoeks S.E., Dunkelgrün M., van Gestel Y.R.B.M., Goei D., Bax J.J.,
Poldermans D. Eur J Vasc Endovasc Surg 2007;34:632-8.
Objective: The Lee-risk index [Lee-index] was developed to predict
major adverse cardiac events [MACE]. However, age is not included as a risk
factor. The aim was to assess the value of the Lee-index in vascular surgery
patients among different age categories.
Methods: Of 2 642 patients cardiovascular risk factors were noted to
calculate the Lee-index. Patients were divided into four age categories;
 55(n  396), 56–65(n  650), 66–75(n  1 058) and 75 years
(n  538). Outcome measures were postoperative MACE (cardiac death,
MI, coronary revascularization and heart failure). The performance of the
Lee-index was determined using C-statistics within the four age groups.
Results: The incidence of MACE was 10.9%, for Lee-index 1, 2 and
3; 6%, 13% and 20%, respectively. However, the prognostic value
differed among age groups. The predictive value for MACE was highest
among patients under 55 year (0.76 vs 0.62 of patients aged  75). The
prediction of MACE improved in elderly (aged  75) after adjusting the
Lee-index with age, revised risk of operation (low, low-intermediate,
high-intermediate and high-risk procedures) and hypertension (0.62 to
0.69).
Conclusion: The prognostic value of the Lee-index is reduced in
elderly vascular surgery patients, adjustment with age, risk of surgical pro-
cedure, and hypertension improves the Lee-index significantly.
The Relationship between Hospital Case Volume and Outcome from
Carotid Endartectomy in England from 2000 to 2005
Holt P.J.E., Poloniecki J.D., Loftus I.M., Thompson M.M. Eur J Vasc
Endovasc Surg 2007;34:646-54.
Objectives: To assess the outcome of carotid endarterectomy in En-
gland with respect to the hospital case-volume.
Methods: Data were from English Hospital Episode Statistics (2000–
2005). Admissions were classified as elective or emergency. Risk-adjusted
data were analysed through modelling of death rate, complication rate and
length of admission with regard to the year of procedure and annual hospital
volume of surgery. Hospitals with elevated death rates were identified and
the evidence quantified that they had outlying mortality rates.
Results: There were 280 081 diagnoses of extra-cranial atherosclerotic
arterial disease in which 18 248 CEA were performed. The mean mortality
rates were 1.04% for elective and 3.16% for emergency CEA. A volume-
related improvement in mortality (p  0.047) was seen for elective CEA.
Length of stay decreased as annual volume increased for elective and
emergency CEA (p  0.001). 20% of the operations were performed in
67.1% of the hospitals, each of which performed fewer than 10 CEA per
annum. A number of hospitals had elevated death rates.
Conclusions:Volume-related improvements in outcome were demon-
strated for elective CEA. Minimum volume-criteria of 35 CEA per annum
should be established in England. Hospitals performing low annual volumes
of surgery should consider arrangements to network services.
Carotid Artery Stenting in a Single Center: Are Six Years of Experience
Enough to Achieve the Standard of Care?
Setacci C., Chisci E., de Donato G., Setacci F., Sirignano P., Galzerano G.
Eur J Vasc Endovasc Surg 2007;34:655-62.
Objectives: This study aims to determine safety, short and mid-term
outcomes of Carotid Artery Stenting (CAS) and Endarterectomy (CEA)
during the last 6 years in a single vascular surgery center.
Methods: We retrospectively reviewed 2624 consecutive carotid revas-
cularizations performed between December 2000 and December 2006 in
2176 patients with severe carotid artery stenosis (symptomatic 70%,
asymptomatic 80%), of which 1589 were CEA and 1035 CAS. Patients
were followed up at 1, 3, 6 and 12 months after the procedure and then
yearly.
Results: The percutaneous procedure was successful in 99.2% of the
cases. No intra-procedural death occurred. The overall death and stroke
rates at 30 days, 1 year and 3 years were 1.54%, 2.86%, 7.43% in the CAS
group and 2.07%, 3.55%, 6.95% in the CEA group, respectively (p value not
significant in any case).
Conclusions: At our vascular surgery centre the results of CEA and
CAS are similar. CAS has become our standard of care in preventing strokes
and is an effective alternative to CEA for low-risk patients as well.
Endovascular Treatment (EVT) of Acute Traumatic Lesions of the
Descending Thoracic Aorta – 7 Years’ Experience
Orend K.H., Zarbis N., Schelzig H., Halter G., Lang G., Sunder-Plassmann
L. Eur J Vasc Endovasc Surg 2007;34:666-72.
Objectives: To present a single centers’ 7-year experience in the
endovascular treatment of acute traumatic lesions of the descending thoracic
aorta (ATL of the DTA).
Materials &methods: Between March 1999 and December 2006, 34
consecutive acute traumatic lesions of the descending aorta (23 men, mean
age 44 years) were treated endovascularly. Stentgrafts used were TAG
Excluder, Zenith TX2 and Talent. In 23 patients the Left Subclavian Artery
(LSA) was covered. Mean procedural duration was 20 to 75 minutes.
Results: Exclusion of the rupture site was achieved in all cases with no
conversion to open surgery. Overall 30-day mortality was 8.8%. Two pa-
tients died on post operative day (pod) 1 and one on pod 22 from cranial
injuries. No death or neurological deficit related to the endovascular treat-
ment was reported. Four type I endoleaks required treatment either by
balloon reexpansion (n  2) or by additional stentgraft implantation
(n  2). In two patients the stentgraft collapsed totally several days postop-
eratively. Two patients required secondary surgical procedures (iliac access
complication and revascularisation of the left subclavian artery n  1). The
average follow-up was 43.8 months (1–93 months). No stentgraft related
abnormality has been subsequently documented.
Conclusions: The endovascular treatment of ATL of the DTA may
offer the best means of therapy in a polytrauma patient.
Endovascular Ruptured Abdominal Aortic Aneurysm Repair (EVRAR):
A Systematic Review
Harkin D.W., Dillon M., Blair P.H., Ellis P.K., Kee F. Eur J Vasc Endovasc
Surg 2007;34:673-81.
Background: To review evidence supporting the use of endovascular
ruptured aneurysm repair (EVRAR) for treatment of ruptured abdominal
aortic aneurysm (RAAA).
Methods: A systematic review of the medical literature was performed
for relevant studies. We searched a number of electronic databases and
hand-searched relevant journals until November 2006 to identify studies for
inclusion. We considered studies in which patients with a confirmed rup-
tured abdominal aortic aneurysm were treated with EVRAR, which reported
endpoints of mortality and major complications.
Results: There was 1 randomised controlled trial (RCT), 33 non-
randomised case series (24 retrospective and 9 prospective) reports were
identified comparing EVRAR (n  891) with conventional open surgical
repair for the treatment of RAAA. Whilst no benefit in the primary
outcome of mortality was noted in the only RCT, evidence from
non-randomised studies suggest that EVRAR is feasible in selected
patients, where it may be associated with a trend towards reductions in
blood loss, duration of intensive care treatment, early complications, and
mortality.
Conclusions: For the treatment of symptomatic or ruptured abdomi-
nal aortic aneurysm, emergency endovascular repair (EVRAR) is feasible in
selected patients, with early outcomes comparable to best conventional open
surgical repair for the treatment of RAAA.
Occupational Capacity Following Surgical Revascularization for Lower
Limb Claudication
Vohra R.S., Coughlin P.A., Gough M.J. Eur J Vasc Endovasc Surg 2007;
34:709-13.
Objectives: Little is known about patient’s ability to return to work
following surgical revascularization for lower limb claudication. A retrospec-
tive cohort study was performed to determine the effect of lower limb
surgical revascularization on subsequent employment status.
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Design and methods: Patients who had undergone surgical revascu-
larization between February 2001 and February 2005 and who were aged
65 years, were identified from a prospective database and contacted via a
postal questionnaire.
Results: Of 139 patients identified 19 had died. Questionnaires were
returned by 80/120 patients (66.7%). Of these 8, 36 and 36 patients had
undergone aortic, groin or infra-inguinal procedures respectively. Pre-oper-
atively, 59 were employed, 17 unemployed and 4 retired. Post-operatively,
51 returned to work, 16 were unemployed, and 13 retired. Those who
retired post-operatively were significantly older (p  0.05) than the remain-
der. After a median hospital stay of 15 (iqr 4–45) days those returning to
work did so after a further 26 (iqr 7–112) days, although this was delayed
following aortic procedures (p  0.05) and in patients with non-intermedi-
ate occupations (p  0.05).
Conclusions: Two thirds of potentially employable patients with clau-
dication return to work following surgery including all those undergoing
lower limb revascularization who were employed pre-operatively. This is
influenced by age, the type of procedure and pre-operative occupation. This
data can be used to predict return to work in patients requiring surgery for
intermittent claudication.
Long-term Results of Surgical Repair of Popliteal Artery Aneurysm
Davies R.S.M., Wall M., Rai S., Simms M.H., Vohra R.K., Bradbury A.W.,
Adam D.J. Eur J Vasc Endovasc Surg 2007;34:714-8.
Objective: To determine the long-term outcome of surgical repair of
popliteal artery aneurysms (PAA).
Methods: A retrospective review of consecutive patients who under-
went surgical PAA repair in two vascular surgery units between 1988 and
2006 was performed. Primary and secondary graft patency, limb salvage and
patient survival rates were determined using Kaplan-Meier methods.
Results: 48 patients underwent repair of 63 PAAs (ligation and by-
pass45, interposition grafting18). The 5-year primary graft patency,
secondary graft patency, limb salvage and patient survival rates were 75%,
95%, 98% and 81%, respectively. The 10-year primary graft patency rates
were significantly lower for emergency cases (59%) compared with elective
cases (66%) (p  0.0023). Thirteen patients (16 PAAs) required a total of
20 late re-interventions. Duplex ultrasound was available in 33 of 45 PAAs
treated by ligation and bypass. Five(15%) PAAs demonstrated perfusion of
the aneurysm sac at median(range) follow up of 75(1–246) months after
primary repair and two of these required emergency re-operation.
Conclusions: These data demonstrate that surgical PAA repair is
associated with excellent long-term durability and provide an important
benchmark with which to compare results of endovascular PAA repair.
Patients treated using the ligation and bypass technique should be enrolled
in an aneurysm sac surveillance program.
Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided
Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-
Blind Trial with 2 Year-Follow-up. “The 3/1 Study”
Hamel-Desnos C., Ouvry P., Benigni J.-P., Boitelle G., Schadeck M.,
Desnos P., Allaert F.-A. Eur J Vasc Endovasc Surg 2007;34:723-9.
Objectives: To compare 1% and 3% POL foam in treating the great
saphenous vein (GSV) by ultrasound guided sclerotherapy.
Design: Multicentre, prospective, randomised, double-blind trial with
2 year-follow-up.
Patients and methods: 148 patients with GSV reflux (saphenous
trunk diameter 4–8 mm) were randomised to undergo ultrasound guided
foam sclerotherapy using either 1% or 3% POL foam in a single session. Foam
production was standardised using a sterile disposable syringe kit including
sterile air and the Turbofoam® machine. Duplex ultrasonography was used
to assess the outcome at 3 weeks, 6 months, 1 year, 18 months and 2 years.
The main criterion of success was the disappearance of the venous reflux.
The length of occlusion of the vein (only measured at 3 week-echography
assessment) was a secondary criterion. Side effects were assessed.
Results: 74 patients were included in each group. The mean volume of
foam injected was 4.4 ml for the 3% group and 4.6 ml for the 1% group.
After 3 weeks, reflux was abolished in 96% (71 patients) of the 3% group and
88% (68 patients) of the 1% group (NS). The mean occlusion length of the
vein was 38 cm for the 3% group and 34 for the 1% group (NS). After
2-years, reflux was absent in 69% of the 3% group and 68% of the 1% group
(NS). 14 patients were lost to follow-up at 2 years.
Conclusion: This study demonstrates equivalent efficacy for 1% POL
and 3% POL foam in sclerotherapy of the GSV where the trunk is less than
8 mm in diameter. These data obtained two years of follow-up confirm our
previously reported 6 month-follow-up data published in 2005.
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